Immunotherapy breakthrough: one year may be enough for some advanced cancers
Knowledge-focused
Completed
This study looked at 161 people with advanced solid tumors (like lung, bladder, skin, and kidney cancers) who had already been on immunotherapy (PD-1/PD-L1 inhibitors) for one year and whose disease was stable. Half stopped treatment, and half continued. The goal was to see if st…
Phase: PHASE3 • Sponsor: Dan Zandberg • Aim: Knowledge-focused
Last updated Apr 29, 2026 03:57 UTC